Golimumab Subcutaneous and Pms-Sodium Polystyrene Sulfonate
Determining the interaction of Golimumab Subcutaneous and Pms-Sodium Polystyrene Sulfonate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: golimumab
Brand name: Simponi, Simponi SmartJect, Simponi Aria
Synonyms: Golimumab
Generic Name: sodium polystyrene sulfonate
Brand name: Kalexate, Kayexalate, Kionex
Synonyms: Sodium polystyrene sulfonate, Sodium Polystyrene Sulfonate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Golimumab Subcutaneous-Pneumococcal 13-valent conjugate vaccine
- Golimumab Subcutaneous-Pneumococcal 13-valent vaccine, diphtheria conjugate Intramuscular
- Golimumab Subcutaneous-Pneumococcal Conjugate Vaccine (13-Valent)
- Golimumab Subcutaneous-Pneumococcal Conjugate Vaccine (7-Valent)
- Golimumab Subcutaneous-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Golimumab Subcutaneous-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Pms-Sodium Polystyrene Sulfonate-GoLYTELY
- Pms-Sodium Polystyrene Sulfonate-Gonadorelin
- Pms-Sodium Polystyrene Sulfonate-Gonadorelin Intravenous, Injection
- Pms-Sodium Polystyrene Sulfonate-Gonadotropin, Chorionic
- Pms-Sodium Polystyrene Sulfonate-Gonal-F
- Pms-Sodium Polystyrene Sulfonate-Gonal-f RFF